Cure8 research brief
Why This Matters
Diet is a modifiable factor many people with IBD try to use to feel better. This review summarizes current evidence that a Mediterranean-style eating pattern may help quality of life and is linked to lower inflammation in observational studies, but randomized trials so far are inconclusive.
Who Should Pay Attention
Adult patients with Crohn's disease or ulcerative colitis, dietitians and clinicians advising on nutrition, and researchers designing dietary intervention trials in IBD.
Study Snapshot
What To Know
This is a systematic review (registered on PROSPERO) that pooled 12 studies including 1,615 adults with IBD: 3 randomized controlled trials, 1 single-arm interventional study, and 8 observational studies.
Observational data tended to favor higher MedDiet adherence for improved QoL and lower inflammation (including CRP), but the randomized trials did not show consistent significant effects on inflammatory biomarkers.
The authors emphasize substantial heterogeneity across studies — differences in design, populations, outcome measures, and risk of bias — which prevented meta-analysis and limits how strongly we can interpret the results.
Overall, the review suggests the MedDiet may be beneficial for quality of life and possibly supportive of remission for some patients, but higher-quality, larger RCTs are needed to confirm effects and identify which dietary components matter most.
Keep In Mind
The review is grounded in an abstract-level from Clinical Nutrition ESPEN and notes high heterogeneity and risk-of-bias across included studies. Because randomized evidence is limited and mixed, conclusions are tentative and not definitive guidance for individual care.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.